Close

Jazz Pharmaceuticals (JAZZ) Achieves New Milestone in JZP-110 Phase 3 for Excessive Sleepiness in Narcolepsy

Go back to Jazz Pharmaceuticals (JAZZ) Achieves New Milestone in JZP-110 Phase 3 for Excessive Sleepiness in Narcolepsy